QNTMQuantum Biopharma Ltd. Class B Subordinate Voting Shares
Identity
- Security key
- 20654
- Ticker
- QNTM
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2018-06-07
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- QNTM
Detail
Enriched 2026-08-14 20:47
- Market cap
- $22,374,990.6
- Shares outstanding (class)
- 3,816,937
- Shares outstanding (weighted)
- 6,429,595
- SIC
- —
- Employees
- 7
- Location
- —
- Homepage
- https://www.quantumbiopharma.com
- Description
Quantum BioPharma Ltd is a biopharmaceutical company dedicated to building a portfolio of inventive assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, it is focused on the research and development of its lead compound, Lucid-MS. Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company maintains a portfolio of strategic investments through its wholly owned subsidiary, which represents loans secured by residential or commercial property.